Tri Chemical Laboratories
4369.TTSE PRIMEChemicals
Financials · Standalone
| Fiscal year ended | 2026-01 | 2025-01 | 2024-01 | 2023-01 | 2022-01 | 2021-01 |
|---|---|---|---|---|---|---|
| Revenue | ¥22.8bn | ¥18.2bn | ¥11.0bn | ¥13.6bn | ¥11.5bn | ¥9.9bn |
| Operating income | ¥5.8bn | ¥5.5bn | ¥2.4bn | ¥3.9bn | ¥3.3bn | — |
| Ordinary income | ¥5.7bn | ¥6.0bn | ¥5.2bn | ¥8.1bn | ¥4.4bn | ¥3.2bn |
| Total assets | ¥43.6bn | ¥34.8bn | ¥30.4bn | ¥29.0bn | ¥23.7bn | ¥16.4bn |
| Net assets / equity | ¥32.9bn | ¥29.8bn | ¥26.4bn | ¥23.1bn | ¥17.2bn | ¥9.6bn |
| EPS (basic) | ¥131.05 | ¥133.3 | ¥130.79 | ¥201.78 | ¥98.31 | ¥74.61 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 2
| Period | Form | Figures |
|---|---|---|
| 2026-02-01 → 2026-07-31 | Half-year | 67 figures · EDINET |
| 2025-02-01 → 2026-01-31 | Annual | 196 figures · EDINET |
22 more reports are still being processed.